These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 16452183)
1. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways. Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183 [TBL] [Abstract][Full Text] [Related]
2. PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition. Macdonald FH; Yao D; Quinn JA; Greenhalgh DA Oncogene; 2014 Aug; 33(32):4132-43. PubMed ID: 24037529 [TBL] [Abstract][Full Text] [Related]
3. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation. Wang XJ; Liefer KM; Greenhalgh DA; Roop DR Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807 [TBL] [Abstract][Full Text] [Related]
4. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation. Wang XJ; Greenhalgh DA; Roop DR Mol Carcinog; 2000 Mar; 27(3):200-9. PubMed ID: 10708482 [TBL] [Abstract][Full Text] [Related]
5. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: association of v-fos expression with promotion and tumor autonomy. Greenhalgh DA; Wang XJ; Eckhardt JN; Roop DR Cell Growth Differ; 1995 May; 6(5):579-86. PubMed ID: 7544154 [TBL] [Abstract][Full Text] [Related]
6. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha. Greenhalgh DA; Wang XJ; Donehower LA; Roop DR Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135 [TBL] [Abstract][Full Text] [Related]
7. 14-3-3σ/Stratifin and p21 limit AKT-related malignant progression in skin carcinogenesis following MDM2-associated p53 loss. McMenemy CM; Guo D; Quinn JA; Greenhalgh DA Mol Carcinog; 2024 Sep; 63(9):1768-1782. PubMed ID: 38869281 [TBL] [Abstract][Full Text] [Related]
8. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin. Owens DM; Spalding JW; Tennant RW; Smart RC Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738 [TBL] [Abstract][Full Text] [Related]
9. Fos cooperation with PTEN loss elicits keratoacanthoma not carcinoma, owing to p53/p21 WAF-induced differentiation triggered by GSK3beta inactivation and reduced AKT activity. Yao D; Alexander CL; Quinn JA; Chan WC; Wu H; Greenhalgh DA J Cell Sci; 2008 May; 121(Pt 10):1758-69. PubMed ID: 18445683 [TBL] [Abstract][Full Text] [Related]
10. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells. Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535 [TBL] [Abstract][Full Text] [Related]
11. Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression. Darwiche N; Scita G; Jones C; Rutberg S; Greenwald E; Tennenbaum T; Collins SJ; De Luca LM; Yuspa SH Cancer Res; 1996 Nov; 56(21):4942-9. PubMed ID: 8895748 [TBL] [Abstract][Full Text] [Related]
12. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis. Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312 [TBL] [Abstract][Full Text] [Related]
14. TGF alpha and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas. Wang XJ; Greenhalgh DA; Lu XR; Bickenbach JR; Roop DR Oncogene; 1995 Jan; 10(2):279-89. PubMed ID: 7530825 [TBL] [Abstract][Full Text] [Related]
15. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis. Lee S; Chari NS; Kim HW; Wang X; Roop DR; Cho SH; DiGiovanni J; McDonnell TJ Mol Carcinog; 2007 Dec; 46(12):949-57. PubMed ID: 17538944 [TBL] [Abstract][Full Text] [Related]
16. Protection against malignant conversion in SENCAR mouse skin by all trans retinoic acid: inhibition of the ras p21-processing enzyme farnesyltransferase and Ha-ras p21 membrane localization. Agarwal R; Mohan RR; Ahmad N; Mukhtar H Mol Carcinog; 1996 Sep; 17(1):13-22. PubMed ID: 8876671 [TBL] [Abstract][Full Text] [Related]
17. Cooperation between v-fos and v-rasHA induces autonomous papillomas in transgenic epidermis but not malignant conversion. Greenhalgh DA; Quintanilla MI; Orengo CC; Barber JL; Eckhardt JN; Rothnagel JA; Roop DR Cancer Res; 1993 Nov; 53(21):5071-5. PubMed ID: 7693330 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis. Roop DR; Krieg TM; Mehrel T; Cheng CK; Yuspa SH Cancer Res; 1988 Jun; 48(11):3245-52. PubMed ID: 2452688 [TBL] [Abstract][Full Text] [Related]
19. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma. Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701 [TBL] [Abstract][Full Text] [Related]
20. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin. Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]